{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T18:31:33Z","timestamp":1790965893989,"version":"4.1.0"},"reference-count":73,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["U54HD071594"],"award-info":[{"award-number":["U54HD071594"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","sfnmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Fetal and Neonatal Medicine"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.siny.2020.101183","type":"journal-article","created":{"date-parts":[[2020,11,26]],"date-time":"2020-11-26T02:22:43Z","timestamp":1606357363000},"page":"101183","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"title":["Pharmacokinetics, pharmacodynamics and metabolism of caffeine in newborns"],"prefix":"10.1016","volume":"25","author":[{"given":"Jacob V.","family":"Aranda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kay D.","family":"Beharry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.siny.2020.101183_bib1","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0022-3476(77)80718-X","article-title":"Efficacy of caffeine in treatment of apnea in the low-birth-weight infant","volume":"90","author":"Aranda","year":"1977","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.siny.2020.101183_bib2","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1542\/peds.15.2.124","article-title":"Citric acid metabolism in infants during the neonatal period","volume":"15","author":"Gittleman","year":"1955","journal-title":"Pediatrics"},{"key":"10.1016\/j.siny.2020.101183_bib3","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1542\/peds.9.1.38","article-title":"Blood sugar and citric acid levels in newborn infants","volume":"9","author":"Gittleman","year":"1952","journal-title":"Pediatrics"},{"key":"10.1016\/j.siny.2020.101183_bib4","first-page":"255","article-title":"The metabolism of citric acid by infants","volume":"20","author":"Smith","year":"1940","journal-title":"J\u00a0Nutr"},{"key":"10.1016\/j.siny.2020.101183_bib5","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S0022-3476(79)80047-5","article-title":"Pharmacokinetic profile of caffeine in the premature newborn infant with apnea","volume":"94","author":"Aranda","year":"1979","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.siny.2020.101183_bib6","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0095-5108(18)31165-5","article-title":"Methylxanthines in apnea of prematurity","volume":"6","author":"Aranda","year":"1979","journal-title":"Clin Perinatol"},{"key":"10.1016\/j.siny.2020.101183_bib7","first-page":"326","article-title":"Relationship of dose and plasma concentrations of caffeine and ventilation in neonatal apnea","volume":"5","author":"Turmen","year":"1981","journal-title":"Semin Perinatol"},{"key":"10.1016\/j.siny.2020.101183_bib8","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/S0022-3476(81)80038-8","article-title":"The efficacy of caffeine in the treatment of recurrent idiopathic apnea in premature infants","volume":"99","author":"Murat","year":"1981","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.siny.2020.101183_bib9","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1592\/phco.20.7.644.35167","article-title":"Caffeine citrate for the treatment of apnea of prematurity: a double-blind, placebo-controlled study","volume":"20","author":"Erenberg","year":"2000","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.siny.2020.101183_bib10","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/S0022-3476(87)80569-3","article-title":"Theophylline versus caffeine: comparative effects in treatment of idiopathic apnea in the preterm infant","volume":"110","author":"Bairam","year":"1987","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.siny.2020.101183_bib11","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1056\/NEJMoa054065","article-title":"Caffeine for apnea of prematurity trial group. Caffeine therapy for apnea of prematurity","volume":"354","author":"Schmidt","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.siny.2020.101183_bib12","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1056\/NEJMoa073679","article-title":"Caffeine for Apnea of Prematurity Trial Group. Long-term effects of caffeine therapy for apnea of prematurity","volume":"357","author":"Schmidt","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.siny.2020.101183_bib13","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1001\/jama.2011.2024","article-title":"Caffeine for Apnea of Prematurity (CAP) Trial Investigators. Survival without disability to age 5 years after neonatal caffeine therapy for apnea of prematurity","volume":"307","author":"Schmidt","year":"2012","journal-title":"J\u00a0Am Med Assoc"},{"key":"10.1016\/j.siny.2020.101183_bib14","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1001\/jamapediatrics.2017.0238","article-title":"Caffeine for Apnea of Prematurity (CAP) Trial Group. Academic performance, motor function, and behavior 11 years after neonatal caffeine citrate therapy for apnea of prematurity: an 11-Year follow-up of the CAP randomized clinical trial","volume":"171","author":"Schmidt","year":"2017","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.siny.2020.101183_bib15","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.jpeds.2014.04.016","article-title":"Caffeine for Apnea of Prematurity Trial investigators. Reduction in developmental coordination disorder with neonatal caffeine therapy","volume":"165","author":"Doyle","year":"2014","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.siny.2020.101183_bib16","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3109\/14767058.2010.517704","article-title":"Caffeine impact on neonatal morbidities","volume":"23","author":"Aranda","year":"2010","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.siny.2020.101183_bib17","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1056\/NEJM197608192950803","article-title":"Pharmacokinetic aspects of theophylline in premature newborns","volume":"295","author":"Aranda","year":"1976","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.siny.2020.101183_bib18","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/BF00606424","article-title":"Pharmacokinetic aspects of caffeine in premature infants with apnoea","volume":"22","author":"Gorodischer","year":"1982","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.siny.2020.101183_bib19","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000480966","article-title":"Caffeine pharmacokinetics in preterm infants older than 2 weeks","volume":"12","author":"Pearlman","year":"1989","journal-title":"Dev Pharmacol Ther"},{"key":"10.1016\/j.siny.2020.101183_bib20","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1159\/000480570","article-title":"Pharmacokinetic aspects of caffeine in premature neonates","volume":"16","author":"De Carolis","year":"1991","journal-title":"Dev Pharmacol Ther"},{"key":"10.1016\/j.siny.2020.101183_bib21","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/00007691-199606000-00005","article-title":"Population pharmacokinetics of caffeine in neonates and young infants","volume":"18","author":"Thomson","year":"1996","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.siny.2020.101183_bib22","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s002280050276","article-title":"Population pharmacokinetics of caffeine in premature neonates","volume":"52","author":"Falc\u00e3o","year":"1997","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.siny.2020.101183_bib23","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/S0009-9236(97)90097-7","article-title":"Population pharmacokinetics of intravenous caffeine in neonates with apnea of prematurity","volume":"61","author":"Lee","year":"1997","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.siny.2020.101183_bib24","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1046\/j.1365-2125.2002.01589.x","article-title":"Caffeine in apnoeic Asian neonates: a sparse data analysis","volume":"54","author":"Lee","year":"2002","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.siny.2020.101183_bib25","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1097\/FTD.0b013e3181898b6f","article-title":"Caffeine citrate treatment for extremely premature infants with apnea: population pharmacokinetics, absolute bioavailability, and implications for therapeutic drug monitoring","volume":"30","author":"Charles","year":"2008","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.siny.2020.101183_bib26","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/j.1365-2125.2012.04392.x","article-title":"Dried blood spots and sparse sampling: a practical approach to estimating pharmacokinetic parameters of caffeine in preterm infants","volume":"75","author":"Patel","year":"2013","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.siny.2020.101183_bib27","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/bcp.13001","article-title":"Salivary caffeine concentrations are comparable to plasma concentrations in preterm infants receiving extended caffeine therapy","volume":"82","author":"Dobson","year":"2016","journal-title":"Br J Clin Pharmacol"},{"issue":"July","key":"10.1016\/j.siny.2020.101183_bib28","article-title":"Developmental population pharmacokinetics of caffeine in Chinese premature infants with apnoea of prematurity: a post-marketing study to support paediatric labelling in China","author":"Gao","year":"2020","journal-title":"Br J Clin Pharmacol"},{"issue":"August","key":"10.1016\/j.siny.2020.101183_bib29","article-title":"Population pharmacokinetic study of caffeine citrate in Chinese premature infants with apnea","author":"Guo","year":"2020","journal-title":"J\u00a0Clin Pharm Therapeut"},{"key":"10.1016\/j.siny.2020.101183_bib30","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1002\/j.1552-4604.1997.tb04356.x","article-title":"Dose-dependent pharmacokinetics and psychomotor effects of caffeine in humans","volume":"37","author":"Kaplan","year":"1997","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.siny.2020.101183_bib31","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/bdd.2510020104","article-title":"The effect of increased caffeine intake on the metabolism and pharmacokinetics of theophylline in man","volume":"2","author":"Monks","year":"1981","journal-title":"J.\u00a0Biopharm Drug Dispos"},{"key":"10.1016\/j.siny.2020.101183_bib32","doi-asserted-by":"crossref","first-page":"432","DOI":"10.2165\/00003088-198510050-00005","article-title":"Theophylline. Pooled michaelis-menten parameters (vmax and km) and implications","volume":"10","author":"Wagner","year":"1985","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.siny.2020.101183_bib33","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/BF03190380","article-title":"Dose dependent pharmacokinetics of theophylline: michaelis-Menten parameters for its major metabolic pathways","volume":"26","author":"Dadashzadeh","year":"2001","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"10.1016\/j.siny.2020.101183_bib34","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2165\/00003088-197904060-00004","article-title":"Dose-dependent elimination kinetics of theophylline","volume":"4","author":"Lesko","year":"1979","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.siny.2020.101183_bib35","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/cpt1979254447","article-title":"Caffeine metabolism in the newborn","volume":"25","author":"Aldridge","year":"1979","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.siny.2020.101183_bib36","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1159\/000480948","article-title":"Effect of formula feeding on oral absorption of caffeine in premature infants","volume":"12","author":"Giacoia","year":"1989","journal-title":"Dev Pharmacol Ther"},{"key":"10.1016\/j.siny.2020.101183_bib37","first-page":"201","article-title":"The role of adenosine receptors in the central action of caffeine","volume":"7","author":"Daly","year":"1994","journal-title":"Pharmacopsychoecologia"},{"key":"10.1016\/j.siny.2020.101183_bib38","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1152\/physiolgenomics.90353.2008","article-title":"Uncovering multiple molecular targets for caffeine using a drug target validation strategy combining A2A receptor knockout mice with microarray profiling","volume":"37","author":"Yu","year":"2009","journal-title":"Physiol Genom"},{"key":"10.1016\/j.siny.2020.101183_bib39","first-page":"261","article-title":"Effects of chronic caffeine on adenosine, dopamine and acetylcholine systems in mice","volume":"328","author":"Shi","year":"1994","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"10.1016\/j.siny.2020.101183_bib40","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0031-6997(25)00450-8","article-title":"Caffeine as an analgesic adjuvant: a review of pharmacology and mechanisms of action","volume":"45","author":"Sawynok","year":"1993","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.siny.2020.101183_bib41","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1080\/1040-830491379245","article-title":"Caffeine use in sports, pharmacokinetics in man, and cellular mechanisms of action","volume":"45","author":"Magkos","year":"2005","journal-title":"Crit Rev Food Sci Nutr"},{"key":"10.1016\/j.siny.2020.101183_bib42","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/j.toxrep.2018.11.002","article-title":"The clinical toxicology of caffeine: a review and case study","volume":"5","author":"Willson","year":"2018","journal-title":"Toxicol Rep"},{"key":"10.1016\/j.siny.2020.101183_bib43","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.bbamem.2006.10.021","article-title":"G\u00a0protein coupled receptor structure and activation","volume":"1768","author":"Kobilka","year":"2007","journal-title":"Biochim Biophys Acta Biomembr"},{"key":"10.1016\/j.siny.2020.101183_bib44","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s002100000313","article-title":"Structure and function of adenosine receptors and their genes","volume":"362","author":"Fredholm","year":"2000","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"10.1016\/j.siny.2020.101183_bib45","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1016\/0024-3205(81)90614-7","article-title":"Adenosine receptors in the central nervous system: relationship to the central actions of methylxanthines","volume":"28","author":"Daly","year":"1981","journal-title":"Life Sci"},{"key":"10.1016\/j.siny.2020.101183_bib46","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1136\/adc.67.4_Spec_No.425","article-title":"Caffeine or theophylline for neonatal apnoea?","volume":"67","author":"Scanlon","year":"1992","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.siny.2020.101183_bib47","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/00007691-199202000-00003","article-title":"Effectiveness and side effects of two different doses of caffeine in preventing apnea in premature infants","volume":"14","author":"Romagnoli","year":"1992","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.siny.2020.101183_bib48","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1046\/j.1440-1754.2003.00207.x","article-title":"Peri-extubation caffeine in preterm neonates: a randomized dose response trial","volume":"39","author":"Steer","year":"2003","journal-title":"J\u00a0Paediatr Child Health"},{"key":"10.1016\/j.siny.2020.101183_bib49","doi-asserted-by":"crossref","first-page":"F499","DOI":"10.1136\/adc.2002.023432","article-title":"High dose caffeine citrate for extubation of preterm infants: a randomised controlled trial. Caffeine Collaborative Study Group Steering Group","volume":"89","author":"Steer","year":"2004","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"10.1016\/j.siny.2020.101183_bib50","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S0140-6736(82)90182-9","article-title":"Plasma caffeine concentrations in outpatients","volume":"2","author":"Smith","year":"1982","journal-title":"Lancet"},{"key":"10.1016\/j.siny.2020.101183_bib51","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1093\/jat\/bkx011","article-title":"Review of caffeine-related fatalities along with postmortem blood concentrations in 51 poisoning deaths","volume":"41","author":"Jones","year":"2017","journal-title":"Anal Toxicol"},{"key":"10.1016\/j.siny.2020.101183_bib52","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1046\/j.1460-9592.2001.00753.x","article-title":"Caffeine intoxication in a premature neonate","volume":"11","author":"Ergenekon","year":"2001","journal-title":"Paediatr Anaesth"},{"key":"10.1016\/j.siny.2020.101183_bib53","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1111\/j.1651-2227.1987.tb10546.x","article-title":"Treatment of caffeine intoxication by exchange transfusion in a newborn","volume":"76","author":"Perrin","year":"1987","journal-title":"Acta Paediatr Scand"},{"key":"10.1016\/j.siny.2020.101183_bib54","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1177\/0310057X9902700316","article-title":"Johnson R Caffeine overdose in a premature infant: clinical course and pharmacokinetics","volume":"27","author":"Anderson","year":"1999","journal-title":"Anaesth Intensive Care"},{"key":"10.1016\/j.siny.2020.101183_bib55","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/0024-3205(83)90119-4","article-title":"Chronic caffeine consumption increases the number of brain adenosine receptors","volume":"32","author":"Boulenger","year":"1983","journal-title":"Life Sci"},{"key":"10.1016\/j.siny.2020.101183_bib56","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1172\/JCI112280","article-title":"Chronic caffeine consumption sensitizes the AI adenosine receptor-adenylate cyclase system in rat cerebral cortex","volume":"77","author":"Green","year":"1986","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.siny.2020.101183_bib57","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/0024-3205(86)90051-2","article-title":"Cross-tolerance studies between caffeine and (-)-N6-(phenylisopropyl)adenosine (PIA) in mice","volume":"38","author":"Ahlijanian","year":"1986","journal-title":"Life Sci"},{"key":"10.1016\/j.siny.2020.101183_bib58","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1172\/JCI110124","article-title":"Tolerance to the humoral and hemodynamic effect of caffeine in man","volume":"67","author":"Robertson","year":"1981","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.siny.2020.101183_bib59","article-title":"Time course of tolerance to the performance benefits of caffeine","volume":"14","author":"Beatriz","year":"2019","journal-title":"PloS One"},{"key":"10.1016\/j.siny.2020.101183_bib60","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1365-2125.1986.tb05246.x","article-title":"Comparative pharmacokinetics of caffeine and its primary demethylated metabolites paraxanthine, theobromine and theophylline in man","volume":"22","author":"Lelo","year":"1986","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.siny.2020.101183_bib61","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1365-2125.1986.tb05247.x","article-title":"Quantitative assessment of caffeine partial clearances in man","volume":"22","author":"Lelo","year":"1986","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.siny.2020.101183_bib62","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0306-3623(95)02014-4","article-title":"The use of caffeine as a metabolic probe for human drug metabolizing enzymes","volume":"27","author":"Miners","year":"1996","journal-title":"Gen Pharmacol"},{"key":"10.1016\/j.siny.2020.101183_bib63","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/978-3-642-13443-2_3","article-title":"Pharmacokinetics and metabolism of natural methylxanthines in animal and man","volume":"200","author":"Arnaud","year":"2011","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.siny.2020.101183_bib64","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1365-2125.1994.tb05706.x","article-title":"Biotransformation of caffeine in human liver microsomes from foetuses, neonates, infants and adults","volume":"37","author":"Cazeneuve","year":"1994","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.siny.2020.101183_bib65","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/clpt.1983.80","article-title":"Variability in caffeine metabolism","volume":"33","author":"Grant","year":"1983","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.siny.2020.101183_bib66","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1203\/01.pdr.0000245909.74166.00","article-title":"Effect of diet on the development of drug metabolism by cytochrome P-450 enzymes in healthy infants","volume":"60","author":"Blake","year":"2006","journal-title":"Pediatr Res"},{"key":"10.1016\/j.siny.2020.101183_bib67","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1177\/00912700122010500","article-title":"Caffeine metabolism in premature infants","volume":"41","author":"al-Alaiyan","year":"2001","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.siny.2020.101183_bib68","doi-asserted-by":"crossref","DOI":"10.1038\/clpt.1988.129","article-title":"Maturation of caffeine metabolic pathways in infancy","volume":"44","author":"Carrier","year":"1988","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.siny.2020.101183_bib69","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0140-6736(78)92188-8","article-title":"Biotransformation of theophylline to caffeine in premature newborn","volume":"2","author":"Bory","year":"1978","journal-title":"Lancet"},{"key":"10.1016\/j.siny.2020.101183_bib70","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1126\/science.515734","article-title":"Metabolism of theophylline to caffeine in human fetal liver","volume":"206","author":"Aranda","year":"1979","journal-title":"Science"},{"key":"10.1016\/j.siny.2020.101183_bib71","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/S0022-3476(79)80246-2","article-title":"Metabolism of theophylline to caffeine in premature newborn infants","volume":"94","author":"Bory","year":"1979","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.siny.2020.101183_bib72","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1136\/adc.54.12.946","article-title":"Maturation of caffeine elimination in infancy","volume":"54","author":"Aranda","year":"1979","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.siny.2020.101183_bib73","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/jp.2015.167","article-title":"Apnea of prematurity and caffeine pharmacokinetics: potential impact on hospital discharge","volume":"36","author":"Doyle","year":"2016","journal-title":"J\u00a0Perinatol"}],"container-title":["Seminars in Fetal and Neonatal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1744165X20301086?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1744165X20301086?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T18:44:37Z","timestamp":1761677077000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1744165X20301086"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":73,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S1744165X20301086"],"URL":"https:\/\/doi.org\/10.1016\/j.siny.2020.101183","relation":{},"ISSN":["1744-165X"],"issn-type":[{"value":"1744-165X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacokinetics, pharmacodynamics and metabolism of caffeine in newborns","name":"articletitle","label":"Article Title"},{"value":"Seminars in Fetal and Neonatal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.siny.2020.101183","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101183"}}